Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China

(2020) Wenhua Liang et al.   LANCET ONCOLOGY

COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter

(2020) Marcus R. Pereira et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Chimeric Antigen Receptor T Cell Therapy During the COVID-19 Pandemic

(2020) Veronika Bachanova et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19?

(2020) Matthew J Frigault et al.   BLOOD

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

(2020) Alba Grifoni et al.   CELL

Functional exhaustion of antiviral lymphocytes in COVID-19 patients

(2020) Meijuan Zheng et al.   Cellular & Molecular Immunology

Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients

(2020) Fengting Yu et al.   CLINICAL INFECTIOUS DISEASES

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China

(2020) Chuan Qin et al.   CLINICAL INFECTIOUS DISEASES

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

(2020) Safiya Richardson et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical and immunological features of severe and moderate coronavirus disease 2019

(2020) Guang Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

The many faces of the anti-COVID immune response

(2020) Santosha A. Vardhana et al.   JOURNAL OF EXPERIMENTAL MEDICINE

COVID-19 in persons with chronic myeloid leukaemia

(2020) Weiming Li et al.   LEUKEMIA

Temporal dynamics in viral shedding and transmissibility of COVID-19

(2020) Xi He et al.   NATURE MEDICINE

Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System

(2020) Vikas Mehta et al.   Cancer Discovery

Real-World Issues and Potential Solutions in Hematopoietic Cell Transplantation during the COVID-19 Pandemic: Perspectives from the Worldwide Network for Blood and Marrow Transplantation and Center for International Blood and Marrow Transplant Research Health Services and International Studies Committee

(2020) Ghada Algwaiz et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent

(2020) Alessio Mazzoni et al.   JOURNAL OF CLINICAL INVESTIGATION

A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward

(2020) Bo Wang et al.   Journal of Hematology & Oncology

Determinants of COVID-19 disease severity in patients with cancer

(2020) Elizabeth V. Robilotti et al.   NATURE MEDICINE

Infection during the first year in patients treated with CD19 CAR T cells for diffuse large B cell lymphoma

(2020) Kitsada Wudhikarn et al.   Blood Cancer Journal

Clinical features of familial clustering in patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Jinzhong Li et al.   VIRUS RESEARCH

Cytomegalovirus Reactivation Promotes CD8+ T Cell Subset Recovery after Unmodified Allogeneic Hematopoietic Cell Transplantation

(2019) Tania Jain et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Minimal Residual Disease (MRD) Assessment before and after Autologous Hematopoietic Cell Transplantation (AutoHCT) and Maintenance for Multiple Myeloma (MM): Results of the Prognostic Immunophenotyping for Myeloma Response (PRIMeR) Study

(2019) Theresa E. Hahn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire

(2015) Yvonne Suessmuth et al.   BLOOD

Spatial Map of Human T Cell Compartmentalization and Maintenance over Decades of Life

(2014) Joseph J.C. Thome et al.   CELL

T cell repertoire following autologous stem cell transplantation for multiple sclerosis

(2014) Paolo A. Muraro et al.   JOURNAL OF CLINICAL INVESTIGATION

Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation

(2013) Jeroen W J van Heijst et al.   NATURE MEDICINE

A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells

(2011) A. V. Singh et al.   BLOOD

How I treat late effects in adults after allogeneic stem cell transplantation

(2010) B. N. Savani et al.   BLOOD

Phase 1 First-in-Human Trial of the Vascular Disrupting Agent Plinabulin(NPI-2358) in Patients with Solid Tumors or Lymphomas

(2010) M. M. Mita et al.   CLINICAL CANCER RESEARCH

Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma

(2008) Tomer Mark et al.   BRITISH JOURNAL OF HAEMATOLOGY